Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial-Reference-Cited by-同舟云学术

Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial

Published:2015-06 Issue:9984 Volume:385 Page:2272-2279
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Zhu Feng-Cai,Hou Li-Hua,Li Jing-Xin,Wu Shi-Po,Liu Pei,Zhang Gui-Rong,Hu Yue-Mei,Meng Fan-Yue,Xu Jun-Jie,Tang Rong,Zhang Jin-Long,Wang Wen-Juan,Duan Lei,Chu Kai,Liang Qi,Hu Jia-Lei,Luo Li,Zhu Tao,Wang Jun-Zhi,Chen Wei

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections;N Engl J Med,2014

2. Chimpanzee adenovirus vector Ebola vaccine—preliminary report;Ledgerwood;N Engl J Med,2014

3. mAbs and Ad-vectored IFN-alpha therapy rescue Ebola-infected nonhuman primates when administered after the detection of viremia and symptoms;Qiu;Sci Transl Med,2013

4. Emerging diseases. On the trail of Ebola and Marburg viruses;Balter;Science,2000

5. Marburg and Ebola viruses;Feldmann;Adv Virus Res,1996

Cited by 155 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging and reemerging infectious diseases: global trends and new strategies for their prevention and control;Signal Transduction and Targeted Therapy;2024-09-11

2. Current updates on the epidemiology, pathogenesis and development of small molecule therapeutics for the treatment of Ebola virus infections;Asian Pacific Journal of Tropical Medicine;2024-07

3. A causal multiomics study discriminates the early immune features of Ad5-vectored Ebola vaccine recipients;The Innovation;2024-05

4. Perceptions, attitudes, and willingness of healthcare and frontline workers to participate in an Ebola vaccine trial in Uganda;Vaccine;2024-04

5. An adenovirus-vectored vaccine based on the N protein of feline coronavirus elicit robust protective immune responses;Antiviral Research;2024-03